Bluebird Myeloma Treatment Delays Cancer Progression Bluebird Myeloma Treatment Delays Cancer Progression

Patients with advanced multiple myeloma treated with bluebird bio ' s experimental immunotherapy lived for a median of nearly a year before their cancer worsened, according to data from a small phase I study presented on Friday.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news